Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 81-88 , January 2009

Evaluating the potential of 188Re-SOCTA–trastuzumab as a new radioimmunoagent for breast cancer treatment

  • Tsai-Yueh Luo

      Affiliations

    • Isotope Application Division, Institute of Nuclear Energy Research, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan
    • Corresponding Author InformationCorresponding author. Tel.: +886 3 4711400x7004; fax: +886 3 4711416.
  • ,
  • I-Chang Tang

      Affiliations

    • Isotope Application Division, Institute of Nuclear Energy Research, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan
  • ,
  • Yu-Long Wu

      Affiliations

    • Isotope Application Division, Institute of Nuclear Energy Research, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan
  • ,
  • Kwel-Luen Hsu

      Affiliations

    • Isotope Application Division, Institute of Nuclear Energy Research, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan
  • ,
  • Show-Wen Liu

      Affiliations

    • Chemistry Division, Institute of Nuclear Energy Research, Taoyuan 325, Taiwan
  • ,
  • Hong-Chang Kung

      Affiliations

    • Department of Electrical Engineering, Tung Nan University, Taipei 222, Taiwan
  • ,
  • Ping-Shan Lai

      Affiliations

    • Department of Chemistry, National Chung Hsing University, Taichung 402, Taiwan
  • ,
  • Wuu-Jyh Lin

      Affiliations

    • Isotope Application Division, Institute of Nuclear Energy Research, P.O. Box 3-27, Longtan, Taoyuan 325, Taiwan

Received 18 July 2008 ,Revised 16 October 2008 ,Accepted 21 October 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0969-8051(08)00234-5

doi: 10.1016/j.nucmedbio.2008.10.014

Nuclear Medicine and Biology
Volume 36, Issue 1 , Pages 81-88 , January 2009